Clinical efficacy of high-flow nasal cannula compared to noninvasive ventilation in patients with post-extubation respiratory failure

The Korean Journal of Internal Medicine
Jung-Wan YooChae-Man Lim

Abstract

Post-extubation respiratory failure (PERF) is associated with poor clinica l outcomes. High-f low nasa l cannula (HF NC) ox ygen therapy has been used in patients with respiratory failure, but the clinical benefit in patients with PERF remains unclear. The aim of this study was to evaluate the clinical efficacy of HFNC compared to noninvasive ventilation (NIV) in patients with PERF. A historic retrospective cohort analysis was performed in 28 beds in the medical Intensive Care Unit (ICU) at a single medical center in South Korea. In total, 73 patients with PERF were enrolled: 39 patients who underwent NIV from April 2007 to March 2009 and 34 patients who received HFNC from April 2009 to May 2011. The rate of avoidance of reintubation was not different between the HFNC group (79.4%) and NIV group (66.7%, p = 0.22). All patients with HFNC tolerated the device, whereas five of those with NIV did not tolerate treatment (p = 0.057). The mean duration of ICU stay was significantly shorter in the HFNC group than in the NIV group (13.4 days vs. 20.6 days, p = 0.015). There was no difference in ICU or in-hospital mortality rate. HFNC is likely to be as effective as, and better tolerated than, NIV for treatment of PERF.

References

Jul 1, 1995·American Journal of Respiratory and Critical Care Medicine·A TorresR Rodriguez-Roisin
Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·A EstebanR S Goldwasser
Aug 12, 1998·American Journal of Respiratory and Critical Care Medicine·S K Epstein, R L Ciubotaru
Feb 24, 2001·American Journal of Respiratory and Critical Care Medicine·UNKNOWN Organized jointly by the American Thoracic Society, the European Respiratory Society, the European Society of Intensive Care
Jun 22, 2002·JAMA : the Journal of the American Medical Association·Sean P KeenanGary Block
Jun 11, 2004·The New England Journal of Medicine·Andrés EstebanAntonio Anzueto
Oct 15, 2005·American Journal of Respiratory and Critical Care Medicine·Miquel FerrerAntoni Torres
Nov 9, 2005·Critical Care Medicine·Stefano NavaPaolo Navalesi
Oct 13, 2007·Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses·Nicole Groves, Antony Tobin
Sep 29, 2009·Journal of Critical Care·Ravindranath TiruvoipatiJohn Botha
Aug 10, 2010·American Journal of Respiratory and Critical Care Medicine·Mariano EsperattiAntoni Torres
Mar 8, 2011·Journal of Critical Care·Fernando Frutos-VivarAntonio Anzueto
Jul 19, 2011·Critical Care Medicine·Arnaud W ThilleLaurent Brochard
Sep 29, 2011·Intensive Care Medicine·Benjamin SztrymfJean-Damien Ricard
Oct 11, 2013·The New England Journal of Medicine·Brett J ManleyPeter G Davis

❮ Previous
Next ❯

Citations

Dec 1, 2017·International Anesthesiology Clinics·Shaun L Thompson, Steven J Lisco
Mar 7, 2019·Tuberculosis and Respiratory Diseases·Hyunseung NamUNKNOWN Korean NIV Study Group
Feb 1, 2018·Acute and Critical Care·Dong Hyun LeeChae-Man Lim
Feb 23, 2021·Global Pediatric Health·Ameer Al-HadidiParas Khandhar

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.